Market Cap 36.32M P/E - EPS this Y - Ern Qtrly Grth -
Income -3.57M Forward P/E - EPS next Y - 50D Avg Chg -6.00%
Sales 825.46k PEG - EPS past 5Y - 200D Avg Chg 5.00%
Dividend N/A Price/Book 3.15 EPS next 5Y - 52W High Chg -49.00%
Recommedations 1.00 Quick Ratio 42.78 Shares Outstanding 5.68M 52W Low Chg 61.00%
Insider Own 16.78% ROA -42.56% Shares Float 3.93M Beta 1.66
Inst Own 7.59% ROE -54.36% Shares Shorted/Prior 432.26K/407.38K Price 6.39
Gross Margin 79.33% Profit Margin - Avg. Volume 1,920,998 Target Price -
Oper. Margin -571.96% Earnings Date - Volume 176,645 Change -0.31%
Lexaria Bioscience Corp. News
07/29/21 Lexaria's DehydraTECH-CBD Lowers Blood Pressure
07/28/21 DehydraTECH-Enabled Consumer Products Now Available in Over 7,000 Stores
07/27/21 Lexaria Completes Dosing in Human Clinical Study HYPER-H21-2
07/26/21 Lexaria Receives US$3,817,643 From Warrant Exercises
07/22/21 Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy
07/21/21 Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3
07/15/21 Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council
07/13/21 Lexaria Receives Patent Protection in Japan
07/05/21 Lexaria Announces Voluntary Delisting from the Canadian Securities Exchange to Concentrate Trading on the Nasdaq Capital Markets
06/29/21 Lexaria Announces 2021 Annual Meeting Results
06/28/21 Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
06/21/21 Virtual Conference for Life Sciences Companies Broadcast Live June 24th, 2021
06/17/21 Lexaria Hits Important Anti-Viral Milestone with In Vitro Test of DehydraTECH(TM)
06/15/21 Lexaria Drug Delivery Platform Enables up to Three-Fold Increase in Oral Delivery of Antiviral Drugs
06/09/21 Lexaria Provides Progress Report on Six R&D Programs
06/07/21 Lexaria Issues Progress Report on First Human Clinical Study of 2021, HYPER-H21-1
06/03/21 Lexaria's DehydraTECH(TM)-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 Virus
05/25/21 Lexaria DehydraTECH(TM) 2.0 Outperforms MCT in 2021 R&D Study
05/20/21 Lexaria's Newest DehydraTECH(TM) 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption Results Ever

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

LEXX Chatroom

User Image stocktowatch7 Posted - 4 hours ago

$SPRT, $LEXX described at

User Image Kremahazem Posted - 8 hours ago

$LEXX I wish we can see our banking day like others :)

User Image maximillien Posted - 10 hours ago

$LEXX is the SEC even aware of $LEXX β€˜s existence

User Image WantSomeMONEY Posted - 12 hours ago

$LEXX this thing holds gains like a cup full of holes can hold water

User Image johnny45 Posted - 14 hours ago

$LEXX this thing moves on the tiniest bit of volume $SPY $QQQ

User Image intratio Posted - 16 hours ago

Lexaria Bioscience Corp The algorithm foretells this equity value will depreciate in the short term and is neither a long or short opportunity in the longer term $LEXX

User Image NetworkNewsWire Posted - 17 hours ago

Cardiovascular Disease Drug Market Offers Compelling Potential for First Movers, Innovators in the Space $LEXX $PFE $MRK $NVS $AZN

User Image Newsfilter Posted - 17 hours ago

Cardiovascular Disease Drug Market Offers Compelling Potential for First Movers, Innovators in the Space $AZN $LEXX $MRK $NVS $PFE

User Image PowerbottomBear Posted - 22 hours ago

$LEXX 1 more round of shorting?

User Image relationpure Posted - 1 day ago


User Image pepe7 Posted - 1 day ago


User Image ledsparky Posted - 1 day ago

$LEXX does more action ah and PM πŸ˜•

User Image TheMathematician Posted - 1 day ago

$LEXX Never disappoints!

User Image AceSantoro Posted - 1 day ago

$LEXX Lexaria is confident that its business plan objectives, along with all its operations, are now all set and fully funded, well into the 2022.

User Image stockquote01 Posted - 1 day ago

$LEXX right on target again. Ceo is achieving the game plan They are successful all the time. Nice article

User Image Ringus Posted - 1 day ago

$LEXX $TIRX My two low float long plays. Both making their moves as we speak. TIRX to 12 and LEXX to 22. Holding as long as it takes.

User Image NetworkNewsWire Posted - 1 day ago

$LEXX Steadily Achieving Its Operational and Business Plan Objectives

User Image stockquote01 Posted - 1 day ago

$LEXX my 2 is stocks are doing great today. $TLRY new base and $lexx finally trading normally….

User Image stockquote01 Posted - 1 day ago

$LEXX one day in th next 6 months, this stock will open at 20 and ride to 50$ Mark this

User Image SHIBYYY Posted - 1 day ago

$LEXX and that's why you hold thru the bad days!

User Image GreenTturtle Posted - 1 day ago

$LEXX LEXX find your πŸ† now!

User Image GreenTturtle Posted - 1 day ago

$LEXX πŸ€ πŸ¦πŸ¦πŸ˜πŸ˜πŸ¦„πŸŒ±πŸ€·β€β™‚οΈπŸ™ˆπŸŽπŸŽπŸ˜πŸ˜πŸ¦πŸ¦πŸ¦πŸ†πŸ†πŸ˜Ž

User Image GreenTturtle Posted - 1 day ago

$LEXX chart looking good! Let's go! LEXX!

User Image pmm316 Posted - 1 day ago

$LEXX FINY you funny

User Image Chenming898989 Posted - 1 day ago

$IMVT $LEXX $ATHA $SAVAcheck out $IMVT , $11.75 private investment and dropped to $7, could be back to $11 today!!!

User Image Csnelson Posted - 1 day ago

$LEXX I thought my eyes were playing tricks on me but nope.

User Image Phigment81 Posted - 1 day ago

$LEXX Did this just go from 8% up PM to nothing? Not sure if my internet is shit.

User Image ledsparky Posted - 1 day ago

$LEXX nice PM

User Image CreativiTimothy Posted - 2 days ago

8/2/21 Monday Watchlist Part 1: $BTBT Offering news via F-3 form filled, 20 mil shares at 5.86 to Ionic Ventures LLC, but slow dilution as Ionic will slowly sell the shares. Offering dip got eaten up fast. Added 8.7 last Friday. Key levels: 5.28, 6.3, 7.02, 7.75, 8.77 area, trend line near 8.77, 10, 11, 12.75, 13.86 $SGLB Recent double bottom huge volume on no news. Needs to hold 3.28 area (3.26-3.3), if so can see 3.86 and 4.2+ short-term. Watching for long entry and confirmed 3.28 area support. Key levels: 3.1, 3.26-3.30, 3.43, 3.86, 4.2, 4.4 area $NAOV Bio moving. Key levels: 1.44, trend line near 1.58, 1.95, 2.33, 2.83, 3.45, 3.75. 4.45, 5. Other levels: 2.6, 3.03, 3.24 $XBIO Low float bio on the move. Key levels: 2.28, 2.51, trend line near 2.75, 3.15, 3.78, 4.69, 5.85, 6.64, 7.32 $LEXX Low float biotech attempting to squeeze many times. Key levels: 6.47, 7.24, 8.01, 9.1, 10.5, 11.45, 12.27, 12.99, 14.53, 15.6

User Image ryankay Posted - 2 days ago

$LEXX this stock is going to make some of us rich af